Journal of Fluorescence

, Volume 18, Issue 2, pp 349–355 | Cite as

Spectrofluorimetric Determination of Oxamniquine in Dosage Forms and Spiked Human Plasma through Derivatization with 1-dimethylaminonaphthalene-5-sulphonyl chloride

  • N. El-Enany
  • F. Belal
  • M. Rizk
Original Paper


A sensitive, simple and selective spectrofluorimetric method was developed for the determination of oxamniquine (OXM) in pharmaceutical formulations and biological fluids. The method is based on the reaction between the drug and 1-dimethylaminonaphthalene-5-sulphonyl chloride (dansyl chloride) in presence of 0.5 M sodium carbonate (pH 10) to yield a highly fluorescent derivative that is measured at 445 nm after excitation at 335 nm. The different experimental parameters affecting the development and stability of the reaction product were carefully studied and optimized. The fluorescence concentration plot was rectilinear over the range of 0.02–0.2 μg ml−1 with a lower detection limit (LOD) of 0.007 μg ml−1 and limit of quantitation (LOQ) of 0.02 μg ml−1. The proposed method was successfully applied to the analysis of commercial capsules. The results obtained were in good agreement with those obtained using the official spectrophotometric method. Furthermore, the method was applied for the determination of oxamniquine in spiked human plasma, the mean % recovery (n = 4) is 97.77 ± 1.19. A proposal of the reaction pathway was presented.


Oxamniquine 1-dimethylaminonaphalene-5-sulphonyl chloride Dosage forms Spiked human plasma 


  1. 1.
    Delgado JN, Remers WA (Eds) (1991) Wilson and Gisvold’s text book of organic medicinal and pharmaceutical chemistry, 9th edn, p 184Google Scholar
  2. 2.
    The USP Pharmacopoeia XXIII (1995) NF 18, The US Pharmaceutical Convention, Rockville, p.1120.Google Scholar
  3. 3.
    Hassan SM, Belal F, Sharf-El-Din M, Sultan M (1988) Spectrophotometric determination of some pharmaceutically nitro compounds in their dosage forms. Analyst 113:1807–1809CrossRefGoogle Scholar
  4. 4.
    Bebawy LI, El-Kelani K, Abdel Fattah L, Ahmad AK (1997) Study of 7,7′,8,8′-tetracyanoquinodimethane charge transfer complexes with some lone-pair-donating drugs. J Pharm Sci 86:1030–1033PubMedCrossRefGoogle Scholar
  5. 5.
    Rizk M, Belal F, Ibrahim F, Ahmed SM, El-Enany NM (2000) A simple kinetic spectrophotometric method for the determination of oxamniquine in formulations and spiked biological fluids. J Pharm Biomed Anal 23:503–513PubMedCrossRefGoogle Scholar
  6. 6.
    Korolkovas A, Haraguchi T (1980) Rev. Farm. Bioquim Univ. Sao Paulo, 16, 12. Thro. Chem. Abstr. vol 94, pp 7846e, 1981Google Scholar
  7. 7.
    Woolhouse NM, Wood PR (1977) Determination of oxamniquine in serum. J Pharm Sci 66:429–430PubMedCrossRefGoogle Scholar
  8. 8.
    Jun HW, Radwan MA (1985) Anal Lett 18:1345–1355Google Scholar
  9. 9.
    Pierri EG, Almeida AE, Gremiao MP (2001) Determination of oxamniquine in capsules by HPLC. J Pharm Biomed Anal 26:675–679PubMedCrossRefGoogle Scholar
  10. 10.
    Masimirembwa CM, Hasler JA, Johansson I (1995), Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6. Eur J Clin Pharmacol 48:35–38PubMedGoogle Scholar
  11. 11.
    Abushoffa MA, Clark BJ (1995) Resolution of the enantiomers of oxamniquine by capillary electrophoresis and high-performance liquid chromatography with cyclodextrins and heparin as chiral selectors. J Chromatogr 700:51–58CrossRefGoogle Scholar
  12. 12.
    Noctor TA, Fell AF, Kaye B (1990), High-performance liquid chromatographic resolution of oxamniquine enantiomers: application to in vitro metabolism studies. Chirality 2:269–274PubMedCrossRefGoogle Scholar
  13. 13.
    Fell AF, Noctor TA, Mama JE, Clark BJ (1988) Computer-aided optimisation of drug enantiomer separation in chiral high-performance liquid chromatography. J Chromatogr 434:377–384PubMedCrossRefGoogle Scholar
  14. 14.
    Belal F, Aly FA (1995) Polarographic behavior and determination of oxamniquine in dosage forms. Electroanalysis 7:483–487CrossRefGoogle Scholar
  15. 15.
    Mohamed MY, El-Gendy AE, El-Bardicy MG, Tawakol MS, Ahmed AKS (1996) Spectrosc Lett 29:299–319CrossRefGoogle Scholar
  16. 16.
    Radi A, Belal F (1998) Reaction of electrogenerated oxamniquine radical anion with glutathione. J Electroanal Chem 441:39–42CrossRefGoogle Scholar
  17. 17.
    Rizk M, Belal F, Ibrahim F, Ahmed SM, El-Enany NM (1999) Fluorimetric determination of oxamniquine in biological fluids. Il Farmaco 54:47–50PubMedCrossRefGoogle Scholar
  18. 18.
    Ayad MM (1984) Spectrofluorimetric microdetermination of imidazoline derivatives using 1-dimethylaminonaphthaline-5-sulphonylchloride. Analyst 109:431–1434CrossRefGoogle Scholar
  19. 19.
    Putter J (1979) A fluorometric method for the determination of praziquantel in blood–plasma and urine. Eur J Drug Metab Pharmacokinet 4:143–148PubMedCrossRefGoogle Scholar
  20. 20.
    Frei-Hausler M, Frei RW (1973) An investigation of fluorigenic labelling of chlorophenols with dansyl chloride. J Chromatogr 84:214–220PubMedCrossRefGoogle Scholar
  21. 21.
    Lucca A, Gentilini G, Lopez-Silva S, Soldarini A (2000) Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors By HPLC. Ther Drug Monit 22:271–276PubMedCrossRefGoogle Scholar
  22. 22.
    Dennis Gmur J, Charles Bredl R, Sharon J, Steele SC, Donald R, Devanter V, Pasqua AN (2003) Determination of polymyxin E1 in rat plasma by high-performance liquid chromatography. J Chromatogr B 789:365–372CrossRefGoogle Scholar
  23. 23.
    Houdier S, Perrier S, Defrancq E, Legrand M (2000) A new fluorescent probe for sensitive detection of carbonyl compounds: sensitivity improvement and application to environmental water samples. Anal Chim Acta 412:221–233CrossRefGoogle Scholar
  24. 24.
    Bagdonaite K, Viklund G, Skog K, Kovic M (2006) Analysis of 3 Amino-propionamide: apotential precursor of acrylamide. J Biochem Biophys Methods 69:215–221PubMedCrossRefGoogle Scholar
  25. 25.
    Seiler N (1970) Methods Biochem Anal 18:259PubMedCrossRefGoogle Scholar
  26. 26.
    Guidance for industry bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, May. 2001. (accessed September 1, 2004)
  27. 27.
    Miller JN, Miller JC (2005) Statistics and chemometrics for analytical chemistry, 5th edn. Prentice Hall, England, p 256Google Scholar
  28. 28.
    Iqbal A, Tauqir A (1991) Analytical profile of drug substances. In: Florey K (ed) vol 20. Academic, New York, p 623Google Scholar
  29. 29.
    Rose J (1964) Advanced physico-chemical experiments. Pitman, LondonGoogle Scholar

Copyright information

© The Author(s) 2007

Authors and Affiliations

  1. 1.Department of Analytical Chemistry, Faculty of PharmacyUniversity of MansouraMansouraEgypt
  2. 2.Department of Analytical Chemistry, Faculty of PharmacyUniversity of HelwanCairoEgypt

Personalised recommendations